[NMusers] Modelling scientist positions at Novo Nordisk

From: SI (Steen Hvass Ingwersen) <"SI>
Date: Tue, 22 Sep 2015 13:31:50 +0000

Dear all,
Please be aware of two open positions for modelling scientists at Novo Nord=
isk, located in the Copenhagen area, Denmark. Both positions will be within=
 our CMC area focusing on creating links between formulation/process develo=
pment activities and pharmacokinetic properties in animals and humans

1. Injectables:
The candidate will be involved with establishing mathematical models descri=
bing how protein association affects pharmacokinetics of injectable diabete=
s products, and to predict how it will be influenced by formulation and pro=
cess changes.
We are looking for a person who can fill in this position, and we would be =
grateful if you could consider if this could be of interest to you or perso=
ns in your network.
The job posting can be found here: http://www.novonordisk.com/careers/see-l=
ist-of-all-available-jobs.33210BR.Internal.html

2. Oral products:
The candidate will focus on establishing in-vitro in-vivo correlations (IVI=
VC) for our new range of oral diabetes products, which can be used to predi=
ct how pharmacokinetics will be influenced by formulation and process chang=
es, based on in-vitro measurements of the drug product.
We are looking for a person who can fill in this position, and we would be =
grateful if you could consider if this could be of interest to you or perso=
ns in your network.
The job posting can be found here: http://www.novonordisk.com/careers/see-l=
ist-of-all-available-jobs.33196BR.Internal.html.

For further information regarding the two positions, please contact Rosa Re=
becca Erritzøe Hansen at +45 3075 5657, Thorbjørn Strøm-Hansen at +45=
 3079 1275 or Karina Sinding Thorsøe at +45 3075 6278.
Applications must be submitted online via the two links above.

Kind regards
Steen

____________________________________

Steen Hvass Ingwersen
Principal Modelling Scientist
Quantitative Clinical Pharmacology

Novo Nordisk A/S
Vandtårnsvej 108-110
DK-2860 Søborg
Denmark
+45 4444 8888 (phone)
+45 3079 4847 (mobile)
si_at_novonordisk.com

Facebook<http://www.facebook.com/novonordisk> | Twitter<http://www.twitter.=
com/novonordisk> | LinkedIn<http://www.linkedin.com/company/novo-nordisk> |=
 Youtube<http://www.Youtube.com/novonordisk> | Pinterest<http://www.pintere=
st.com/novonordisk>

Changing diabetes since 1923
Did you know that Novo Nordisk was the first company to introduce insulin t=
o Scandinavia? Find out more here<http://www.novonordisk.com/about_us/histo=
ry/novo-nordisk-history.asp>

This e-mail (including any attachments) is intended for the addressee(s) st=
ated above only and may contain confidential information protected by law. =
You are hereby notified that any unauthorized reading, disclosure, copying =
or distribution of this e-mail or use of information contained herein is st=
rictly prohibited and may violate rights to proprietary information. If you=
 are not an intended recipient, please return this e-mail to the sender and=
 delete it immediately hereafter. Thank you.

Received on Tue Sep 22 2015 - 09:31:50 EDT

This archive was generated by hypermail 2.3.0 : Fri Sep 27 2019 - 16:46:15 EDT